About Humaneva Group
Humaneva Group is a Healthcare company based in Raleigh (United States) founded in 2014 by Tomasz Dabrowski and Karolina Sztajerwald Prokopowicz. It operates as a provider of clinical research data services for oncology other therapeutic areas. Humaneva Group has raised $50 million across 1 funding round from investors including Viking Global Investors. Its chief executive is Tomasz Dabrowski. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Functional Services. Its legal entity is HUMANEVA SPÓŁKA AKCYJNA. Its competitors include Fauna Bio, BeaconCure, Predxbio, Lila Sciences and Prudentia Sciences and 1 more; 5 of its 6 listed competitors have raised funding.
Company details
Humaneva Group was founded in 2014 and is headquartered in Raleigh, United States. Clinical research data services are offered by the company, focusing on oncology and various other therapeutic areas. Operations encompass data management and analysis for clinical trials, supporting pharmaceutical and biotech sectors. Expertise is applied across multiple geographies through partnerships, with leadership provided by co-founders Tomasz Dabrowski as CEO and Karolina Sztajerwald Prokopowicz.
- Headquarters Raleigh, United States
- Founders Tomasz Dabrowski, Karolina Sztajerwald Prokopowicz
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website humaneva.com
- Social LinkedIn
- Legal Name Humaneva Spółka Akcyjna
- Total Equity Funding$50M (USD)
in 1 rounds
- Latest Funding Round$50M (USD), Private Equity Round
Sep 2024
- Investors
Funding Insights of Humaneva Group
Humaneva Group has successfully raised a total of $50M through 1 strategic funding round. The most recent funding activity was a Private Equity Round of $50 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $50M
- Total Rounds 1
- Last Round Private Equity Round — $50M
- First Round $50M
(Sep 2024)
- Investors Count 1
All 1 funding rounds of Humaneva Group with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2024 | $50M | Private Equity Round | – | – |
1 investors in total: 1 institutional.
Investors in Humaneva Group
Humaneva Group has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Viking Global Investors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private investment firm focused on multiple sectors | – | vikingglobal.com | Greenwich, United States |
Investor details for Humaneva Group
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Humaneva Group
2 people are tracked at Humaneva Group (2 in leadership).
| Name | Role | Group |
|---|---|---|
Tomasz Dabrowski | Co-Founder & CEO | Leadership |
Karolina Sztajerwald Prokopowicz | Co-Founder | Leadership |
Complete people profiles for Humaneva Group
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Humaneva Group
2 dated milestones of Humaneva Group across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Humaneva Group is founded.
- Funding First funding round of $50.0M.
Competitors of Humaneva Group
Humaneva Group has 6 listed competitors in our database, 5 of them funded. They include Fauna Bio, BeaconCure, Predxbio, Lila Sciences and Prudentia Sciences, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| faunabio.com | 2018 | Berkeley, United States | $13.1M | 19 | Animal genomics is applied to healthcare advancements by Fauna Bio. | |
| beaconcure.com | 2016 | Tel Aviv, Israel | $40.92M | – | Data analytics and validation software for regulatory submission in the healthcare sector | |
| predxbio.com | 2017 | Pittsburgh, United States | $1.4M | – | AI-based drug discovery and clinical services are provided for biopharma. | |
| lila.ai | 2023 | – | $550M | – | AI-powered platforms for autonomous scientific research are developed. | |
| prudentiasciences.com | 2023 | Cambridge, United States | $7M | – | AI-powered diligence and valuation for drug assets are provided. | |
| privatehealth.com | 2007 | Los Angeles, United States | – | – | Provides personalized healthcare guidance for complex diseases and partnerships. |
Detailed competitors of Humaneva Group
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as Humaneva Group (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Humaneva Group
Complete news archive for Humaneva Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Humaneva Group
Humaneva Group was founded in 2014 and raised its 1st funding round 10 years after it was founded.
Humaneva Group is headquartered in Raleigh, United States. It is registered at Raleigh, North Carolina, United States.
Tomasz Dabrowski is the current CEO of Humaneva Group. They have also founded this company.
Humaneva Group is a funded company, having raised a total of $50M across 1 funding round to date. The company's 1st funding round was a Private Equity Round of $50M, raised on Sep 2024.
Humaneva Group was founded in 2014 and is headquartered in Raleigh, United States. Clinical research data services are offered by the company, focusing on oncology and various other therapeutic areas. Operations encompass data management and analysis for clinical trials, supporting pharmaceutical and biotech sectors. Expertise is applied across multiple geographies through partnerships, with leadership provided by co-founders Tomasz Dabrowski as CEO and Karolina Sztajerwald Prokopowicz.
Humaneva Group's top competitors include Fauna Bio, Predxbio and Lila Sciences.
Humaneva Group has 1 investor. Key investors include Viking Global Investors.
Humaneva Group operates through Humaneva Spółka Akcyjna.